Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Fluxametamide: A novel isoxazoline insecticide that acts via distinctive antagonism of insect ligand-gated chloride channels.

Asahi M, Kobayashi M, Kagami T, Nakahira K, Furukawa Y, Ozoe Y.

Pestic Biochem Physiol. 2018 Oct;151:67-72. doi: 10.1016/j.pestbp.2018.02.002. Epub 2018 Feb 6.

PMID:
30704715
2.

Bacteriuria With CTX-M-8 Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Patient With Incomplete Kawasaki Disease.

Kamijo K, Abe Y, Kagami T, Ugajin K, Mikawa T, Fukuchi K, Tatsuno M, Itabashi K.

Glob Pediatr Health. 2019 Jan 9;6:2333794X18821944. doi: 10.1177/2333794X18821944. eCollection 2019.

3.

High expression level of CD44v8-10 in cancer stem-like cells is associated with poor prognosis in esophageal squamous cell carcinoma patients treated with chemoradiotherapy.

Kagami T, Yamade M, Suzuki T, Uotani T, Tani S, Hamaya Y, Iwaizumi M, Osawa S, Sugimoto K, Baba S, Sugimura H, Miyajima H, Furuta T.

Oncotarget. 2018 Oct 9;9(79):34876-34888. doi: 10.18632/oncotarget.26172. eCollection 2018 Oct 9.

4.

Development of Cell Analysis Software to Evaluate Fibroblastic Changes in Cultivated Corneal Endothelial Cells for Quality Control.

Okumura N, Kobayashi K, Ishida N, Kagami T, Hiwa S, Hiroyasu T, Koizumi N.

Cornea. 2018 Dec;37(12):1572-1578. doi: 10.1097/ICO.0000000000001757.

PMID:
30234679
5.

The Japanese Workplace PERMA-Profiler: A validation study among Japanese workers.

Watanabe K, Kawakami N, Shiotani T, Adachi H, Matsumoto K, Imamura K, Matsumoto K, Yamagami F, Fusejima A, Muraoka T, Kagami T, Shimazu A, L Kern M.

J Occup Health. 2018 Sep 26;60(5):383-393. doi: 10.1539/joh.2018-0050-OA. Epub 2018 Aug 17.

6.

High incidence of autoimmune gastritis in patients misdiagnosed with two or more failures of H. pylori eradication.

Furuta T, Baba S, Yamade M, Uotani T, Kagami T, Suzuki T, Tani S, Hamaya Y, Iwaizumi M, Osawa S, Sugimoto K.

Aliment Pharmacol Ther. 2018 Aug;48(3):370-377. doi: 10.1111/apt.14849. Epub 2018 Jun 19.

PMID:
29920721
7.

Response to "CYP-Mediated Drug-Drug Interaction Is Not a Major Determinant of Attenuation of Antiplatelet Function of Clopidogrel by Vonoprazan".

Kagami T, Furuta T.

Clin Pharmacol Ther. 2018 Jul;104(1):33-34. doi: 10.1002/cpt.1059. Epub 2018 Apr 16. No abstract available.

PMID:
29663346
8.

Involvement of Nectin-Afadin in the Adherens Junctions of the Corneal Endothelium.

Okumura N, Kagami T, Fujii K, Nakahara M, Koizumi N.

Cornea. 2018 May;37(5):633-640. doi: 10.1097/ICO.0000000000001526.

PMID:
29384809
9.

Efficacy of Reduced Dosage of Amoxicillin in an Eradication Therapy for Helicobacter pylori Infection in Patients on Hemodialysis: A Randomized Controlled Trial.

Sahara S, Sugimoto M, Ichikawa H, Kagami T, Sakao Y, Ohashi N, Horio Y, Sugimoto K, Kato A, Furuta T, Yasuda H.

Digestion. 2018;97(2):163-169. doi: 10.1159/000484981. Epub 2018 Jan 8.

PMID:
29310119
10.

Comparison of effect of an increased dosage of vonoprazan versus vonoprazan plus lafutidine on gastric acid inhibition and serum gastrin.

Suzuki T, Kagami T, Uotani T, Yamade M, Hamaya Y, Iwaizumi M, Osawa S, Sugimoto K, Miyajima H, Furuta T.

Eur J Clin Pharmacol. 2018 Jan;74(1):45-52. doi: 10.1007/s00228-017-2324-1. Epub 2017 Oct 6.

PMID:
28986609
11.

Comparative Study of Effects of Vonoprazan and Esomeprazole on Antiplatelet Function of Clopidogrel or Prasugrel in Relation to CYP2C19 Genotype.

Kagami T, Yamade M, Suzuki T, Uotani T, Hamaya Y, Iwaizumi M, Osawa S, Sugimoto K, Umemura K, Miyajima H, Furuta T.

Clin Pharmacol Ther. 2018 May;103(5):906-913. doi: 10.1002/cpt.863. Epub 2017 Oct 13.

PMID:
28875498
12.

Activation of the Rho/Rho Kinase Signaling Pathway Is Involved in Cell Death of Corneal Endothelium.

Okumura N, Fujii K, Kagami T, Makiko N, Kitahara M, Kinoshita S, Koizumi N.

Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6843-6851. doi: 10.1167/iovs.16-20123.

PMID:
28002844
13.

Influence of low-dose proton pump inhibitors administered concomitantly or separately on the anti-platelet function of clopidogrel.

Furuta T, Sugimoto M, Kodaira C, Nishino M, Yamade M, Uotani T, Sahara S, Ichikawa H, Kagami T, Iwaizumi M, Hamaya Y, Osawa S, Sugimoto K, Umemura K.

J Thromb Thrombolysis. 2017 Apr;43(3):333-342. doi: 10.1007/s11239-016-1460-2.

PMID:
27981489
14.

Letter: probing the consequences of potent acid inhibition by vonoprazan - authors' reply.

Kagami T, Furuta T.

Aliment Pharmacol Ther. 2016 Aug;44(3):305. doi: 10.1111/apt.13684. No abstract available.

15.

Four-times-daily Dosing of Rabeprazole with Sitafloxacin, High-Dose Amoxicillin, or Both for Metronidazole-Resistant Infection with Helicobacter pylori in Japan.

Sugimoto M, Sahara S, Ichikawa H, Kagami T, Ban H, Otsuka T, Andoh A, Furuta T.

Helicobacter. 2017 Feb;22(1). doi: 10.1111/hel.12319. Epub 2016 May 23.

PMID:
27213463
16.

Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotype.

Kagami T, Sahara S, Ichikawa H, Uotani T, Yamade M, Sugimoto M, Hamaya Y, Iwaizumi M, Osawa S, Sugimoto K, Miyajima H, Furuta T.

Aliment Pharmacol Ther. 2016 May;43(10):1048-59. doi: 10.1111/apt.13588. Epub 2016 Mar 18.

17.

Identification of Reliable Components in Multivariate Curve Resolution-Alternating Least Squares (MCR-ALS): a Data-Driven Approach across Metabolic Processes.

Motegi H, Tsuboi Y, Saga A, Kagami T, Inoue M, Toki H, Minowa O, Noda T, Kikuchi J.

Sci Rep. 2015 Nov 4;5:15710. doi: 10.1038/srep15710.

18.

One-day front-loading with four doses of rabeprazole followed by a standard twice-daily regimen provides sufficient acid inhibition in extensive metabolizers of CYP2C19.

Kagami T, Sugimoto M, Ichikawa H, Sahara S, Uotani T, Yamade M, Hamaya Y, Iwaizumi M, Osawa S, Sugimoto K, Miyajima H, Furuta T.

Eur J Clin Pharmacol. 2015 Dec;71(12):1467-75. doi: 10.1007/s00228-015-1941-9. Epub 2015 Oct 2.

PMID:
26427705
19.

Factors associated with healing of artificial ulcer after endoscopic submucosal dissection with reference to Helicobacter pylori infection, CYP2C19 genotype, and tumor location: Multicenter randomized trial.

Yoshizawa Y, Sugimoto M, Sato Y, Sahara S, Ichikawa H, Kagami T, Hosoda Y, Kimata M, Tamura S, Kobayashi Y, Osawa S, Sugimoto K, Miyajima H, Furuta T.

Dig Endosc. 2016 Mar;28(2):162-72. doi: 10.1111/den.12544. Epub 2015 Oct 20.

PMID:
26331711
20.

Improvement of gastroesophageal reflux disease in Japanese patients with spinal kyphotic deformity who underwent surgical spinal correction.

Sugimoto M, Hasegawa T, Nishino M, Sahara S, Uotani T, Ichikawa H, Kagami T, Sugimoto K, Yamato Y, Togawa D, Kobayashi S, Hoshino H, Matsuyama Y, Furuta T.

Dig Endosc. 2016 Jan;28(1):50-8. doi: 10.1111/den.12543. Epub 2015 Sep 30.

PMID:
26331612
21.

High Helicobacter pylori cure rate with sitafloxacin-based triple therapy.

Sugimoto M, Sahara S, Ichikawa H, Kagami T, Uotani T, Furuta T.

Aliment Pharmacol Ther. 2015 Aug;42(4):477-83. doi: 10.1111/apt.13280. Epub 2015 Jun 15.

22.

The radish genome and comprehensive gene expression profile of tuberous root formation and development.

Mitsui Y, Shimomura M, Komatsu K, Namiki N, Shibata-Hatta M, Imai M, Katayose Y, Mukai Y, Kanamori H, Kurita K, Kagami T, Wakatsuki A, Ohyanagi H, Ikawa H, Minaka N, Nakagawa K, Shiwa Y, Sasaki T.

Sci Rep. 2015 Jun 9;5:10835. doi: 10.1038/srep10835.

23.

Potent Gastric Acid Inhibition Over 24 Hours by 4-Times Daily Dosing of Esomeprazole 20 mg.

Sahara S, Sugimoto M, Uotani T, Ichikawa H, Yamade M, Kagami T, Hamaya Y, Iwaizumi M, Osawa S, Sugimoto K, Miyajima H, Furuta T.

Digestion. 2015;91(4):277-85. doi: 10.1159/000381419. Epub 2015 Apr 28.

PMID:
25924819
24.

Comparison of acid inhibition with standard dosages of proton pump inhibitors in relation to CYP2C19 genotype in Japanese.

Sugimoto M, Shirai N, Nishino M, Kodaira C, Uotani T, Sahara S, Ichikawa H, Kagami T, Sugimoto K, Furuta T.

Eur J Clin Pharmacol. 2014 Sep;70(9):1073-8. doi: 10.1007/s00228-014-1713-y. Epub 2014 Jul 6.

PMID:
24996380
25.

Eradication of H. pylori infection in patients allergic to penicillin using triple therapy with a PPI, metronidazole and sitafloxacin.

Furuta T, Sugimoto M, Yamade M, Uotani T, Sahara S, Ichikawa H, Kagami T, Yamada T, Osawa S, Sugimoto K, Watanabe H, Umemura K.

Intern Med. 2014;53(6):571-5.

26.

A chalcone isomerase-like protein enhances flavonoid production and flower pigmentation.

Morita Y, Takagi K, Fukuchi-Mizutani M, Ishiguro K, Tanaka Y, Nitasaka E, Nakayama M, Saito N, Kagami T, Hoshino A, Iida S.

Plant J. 2014 Apr;78(2):294-304. doi: 10.1111/tpj.12469. Epub 2014 Mar 14.

27.

Effective selenium volatilization under aerobic conditions and recovery from the aqueous phase by Pseudomonas stutzeri NT-I.

Kagami T, Narita T, Kuroda M, Notaguchi E, Yamashita M, Sei K, Soda S, Ike M.

Water Res. 2013 Mar 1;47(3):1361-8. doi: 10.1016/j.watres.2012.12.001. Epub 2012 Dec 12.

PMID:
23270669
28.

Identification of novel therapeutic targets in microdissected clear cell ovarian cancers.

Stany MP, Vathipadiekal V, Ozbun L, Stone RL, Mok SC, Xue H, Kagami T, Wang Y, McAlpine JN, Bowtell D, Gout PW, Miller DM, Gilks CB, Huntsman DG, Ellard SL, Wang YZ, Vivas-Mejia P, Lopez-Berestein G, Sood AK, Birrer MJ.

PLoS One. 2011;6(7):e21121. doi: 10.1371/journal.pone.0021121. Epub 2011 Jul 6.

29.

Characterization of Pseudomonas stutzeri NT-I capable of removing soluble selenium from the aqueous phase under aerobic conditions.

Kuroda M, Notaguchi E, Sato A, Yoshioka M, Hasegawa A, Kagami T, Narita T, Yamashita M, Sei K, Soda S, Ike M.

J Biosci Bioeng. 2011 Sep;112(3):259-64. doi: 10.1016/j.jbiosc.2011.05.012. Epub 2011 Jun 14.

PMID:
21676651
30.

[A case of hemorrhage from varices of an interposed jejunum after choledochojejunostomy treated successfully by endoscopic injection using α-cyanoacrylate monomer].

Chida T, Kageyama F, Yamada M, Yoshii S, Honjo Y, Takai T, Iwaoka Y, Terai T, Kagami T, Yamazaki S, Suzuki S, Shimoyama S, Kobayashi Y.

Nihon Shokakibyo Gakkai Zasshi. 2010 Oct;107(10):1661-8. Review. Japanese.

PMID:
20938117
31.

Identification and biochemical characterization of the SLC9A7 interactome.

Kagami T, Chen S, Memar P, Choi M, Foster LJ, Numata M.

Mol Membr Biol. 2008 Aug;25(5):436-47. doi: 10.1080/09687680802263046.

PMID:
18654930
32.

Implementation of the modified-SHIRPA protocol for screening of dominant phenotypes in a large-scale ENU mutagenesis program.

Masuya H, Inoue M, Wada Y, Shimizu A, Nagano J, Kawai A, Inoue A, Kagami T, Hirayama T, Yamaga A, Kaneda H, Kobayashi K, Minowa O, Miura I, Gondo Y, Noda T, Wakana S, Shiroishi T.

Mamm Genome. 2005 Nov;16(11):829-37. Epub 2005 Nov 11.

PMID:
16284798
33.
34.

Evaluation of blood-brain barrier transporters by co-culture of brain capillary endothelial cells with astrocytes.

Kido Y, Tamai I, Nakanishi T, Kagami T, Hirosawa I, Sai Y, Tsuji A.

Drug Metab Pharmacokinet. 2002;17(1):34-41.

35.

[Successful treatment of endometrial carcinoma associated with lung metastasis by paclitaxel and carboplatin chemotherapy].

Tohya T, Onoda C, Yoshimura T, Kagami T.

Gan To Kagaku Ryoho. 2004 Jun;31(6):949-51. Japanese.

PMID:
15222119
36.

[Causal attribution and conflict resolution in the Japanese language instruction setting].

Kagami T, Ohbuchi K.

Shinrigaku Kenkyu. 2004 Feb;74(6):531-9. Japanese.

PMID:
15112508
37.

A series of maturity onset diabetes of the young, type 2 (MODY2) mouse models generated by a large-scale ENU mutagenesis program.

Inoue M, Sakuraba Y, Motegi H, Kubota N, Toki H, Matsui J, Toyoda Y, Miwa I, Terauchi Y, Kadowaki T, Shigeyama Y, Kasuga M, Adachi T, Fujimoto N, Matsumoto R, Tsuchihashi K, Kagami T, Inoue A, Kaneda H, Ishijima J, Masuya H, Suzuki T, Wakana S, Gondo Y, Minowa O, Shiroishi T, Noda T.

Hum Mol Genet. 2004 Jun 1;13(11):1147-57. Epub 2004 Apr 21.

PMID:
15102714
38.

High-frequency transformation of Lobelia erinus L. by Agrobacterium-mediated gene transfer.

Tsugawa H, Kagami T, Suzuki M.

Plant Cell Rep. 2004 May;22(10):759-64. Epub 2004 Feb 10.

PMID:
14770264
39.
40.

Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier.

Kido Y, Tamai I, Ohnari A, Sai Y, Kagami T, Nezu J, Nikaido H, Hashimoto N, Asano M, Tsuji A.

J Neurochem. 2001 Dec;79(5):959-69.

43.

A plasmid isolated from phytopathogenic onion yellows phytoplasma and its heterogeneity in the pathogenic phytoplasma mutant.

Kuboyama T, Huang CC, Lu X, Sawayanagi T, Kanazawa T, Kagami T, Matsuda I, Tsuchizaki T, Namba S.

Mol Plant Microbe Interact. 1998 Nov;11(11):1031-7.

44.

Separation of lac dye components by high-speed counter-current chromatography.

Oka H, Ito Y, Yamada S, Kagami T, Hayakawa J, Harada K, Atsumi E, Suzuki M, Suzuki M, Odani H, Akahori S, Maeda K, Nakazawa H, Ito Y.

J Chromatogr A. 1998 Jul 10;813(1):71-7.

PMID:
9697316
45.

Mass spectrometric analysis of tetracycline antibiotics in foods.

Oka H, Ito Y, Ikai Y, Kagami T, Harada K.

J Chromatogr A. 1998 Jul 3;812(1-2):309-19. Review.

PMID:
9691327
47.

[Phylogenetic classification of plant pathogenic mycoplasma].

Namba S, Sawayanagi T, Lu X, Kagami T, Sun L.

Nihon Saikingaku Zasshi. 1998 May;53(2):443-51. Review. Japanese. No abstract available.

PMID:
9654944
48.

Multiple pulmonary nodules after recovery from chickenpox in a patient with chronic lymphocytic leukaemia.

Miyashita Y, Koike H, Misawa A, Shimizu H, Yoshida K, Yasutomi T, Kanai N, Kagami T.

Respirology. 1997 Jun;2(2):135-8.

PMID:
9441126
49.

[Father-son cases of arrythmogenic right ventricular dysplasia treated successfully by radiofrequency catheter ablation].

Nakamura M, Ishikawa R, Aizawa K, Noda Y, Seto T, Kagami T.

Nihon Naika Gakkai Zasshi. 1996 Jan 10;85(1):115-7. Japanese. No abstract available.

PMID:
8871318
50.

Effective monitoring of concentrations of ofloxacin in saliva of patients with chronic respiratory tract infections.

Koizumi F, Ohnishi A, Takemura H, Okubo S, Kagami T, Tanaka T.

Antimicrob Agents Chemother. 1994 May;38(5):1140-3.

Supplemental Content

Loading ...
Support Center